Prosecution Insights
Last updated: October 04, 2026

Acuity Law Group, P.C.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

29 pending office actions • 22 clients • 28 examiners • 21 art units • 0 of 29 (0%) have an AI response strategy ready

Analysis

Acuity Law Group, P.C. is a patent law firm that focuses on the Biotechnology & Pharmaceuticals sector, having handled 1919 career applications. The firm maintains a resolved allowance rate of 80.02 percent, which serves as an indicator of their results in these technical fields. This volume of applications shows a specialization in life sciences.

The firm is currently processing 26 pending office actions. Their average of 4.22 office actions per allowance reflects the nature of biotechnology prosecution, which often requires rounds of negotiation. Practitioners may use this 4.22 average to set expectations for the length and intensity of the patent acquisition process in Biotechnology & Pharmaceuticals.

The 1919 career applications provide a data set for evaluating the firm's performance. The 80.02 percent allowance rate demonstrates an ability to secure patents despite the 4.22 office actions typically required per allowance. These metrics, along with the 26 pending office actions, offer a view of the firm's current and historical prosecution activity.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=1919 apps, methodology: how we score firms)

80.0%
Allowance Rate
n=1919
+0.96σ
Allowance Rate (norm)
n=1919
4.2
OAs to Allowance
n=809
+0.06σ
OAs to Allow (norm)
n=809
1400 days
Time to Allowance
n=809
+16.2pp
Interview Lift
n=1919
29.0%
RCE Rate
n=1919
4.9%
Appeal Rate
n=1919

Rejection Performance (% of received rejections ultimately overcome)

87.3%
§101 Overcome
n=205
83.4%
§102 Overcome
n=332
82.7%
§103 Overcome
n=594
84.4%
§112 Overcome
n=614

Specialization & Scale

A61K, G01N, A61B
Top CPC Subclasses
33%
Top-3 CPC Share
n=1919
1
Practitioners
n=1919
1919.0
Apps / Practitioner
n=1919

Portfolio Summary

29
Total Pending OAs
21
Non-Final OAs
7
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
3
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

17
Hard (59%)
10
Medium (34%)
2
Easy (7%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other3 (10%)
§103 only7 (24%)
§112 only1 (3%)
Double-patenting only1 (3%)
Double-patenting + other3 (10%)
Multi-statute (no §101)14 (48%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

19
Life Sciences
66% of docket
1
Information Tech
3% of docket
0
Communications
0% of docket
2
Semiconductors
7% of docket
2
Mechanical / Eng
7% of docket
5
Business / Other
17% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

290 h
Manual time on pending OAs
58 h
Time saved (low, 20%)
102 h
Time saved (mid, 35%)
2.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KIM, YOUNG J 2 64.8% +18.1%
SONG, HOSUK 1 94.6% +3.0%
HAGHIGHATIAN, MINA 1 46.1% +39.3%
BLUMEL, BENJAMIN P 1 70.8% +30.5%
BALLER, KELSEY E 1 62.4% +59.9%
COLLINS, CYNTHIA E 1 82.2% +9.0%
GEDEON, BRIAN T 1 86.9% +7.2%
DEKARSKE, MADELINE MCGUIRE 1 0.0% +0.0%
CESARE, JOSEPH DAVID 1 — —
GWARTNEY, ELIZABETH A 1 36.0% +34.8%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19025540 MULTI FACTOR AUTHENTICATION SONG, HOSUK —
18642557 BODY-WORN VITAL SIGN MONITOR GEDEON, BRIAN T —

Hard Cases (17)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18036123 TEST DEVICE AND TEST PAPER JARRETT, LORE RAMILLANO 97d overdue
17999185 MEK-INHIBITORS FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTIONS AND/OR COVID-19 CYTOKINE STORM NESTOR, DONNA MICHELLE 89d overdue
17617190 SYSTEM AND METHOD FOR REAL-TIME MULTICOLOR SHORTWAVE INFRARED FLUORESCENCE IMAGING FAYE, MAMADOU 74d overdue
17617284 MICROFLUIDIC CHIP AND MANUFACTURING METHOD THEREFOR KASS, BENJAMIN JOSEPH 73d overdue
18261995 NON-INVASIVE CANCER DETECTION BASED ON DNA METHYLATION CHANGES KIM, YOUNG J 13d
18852335 METHODS AND COMPOSITIONS FOR POTENTIATION OF A LIGAND HAGHIGHATIAN, MINA —
18888122 BIOLOGICAL SAMPLE EXTRACTION BUFFER, AND APPLICATION AND METHOD THEREOF BLUMEL, BENJAMIN P —
18749431 PRESSURE CONTROL SYSTEM, DEVICE AND METHOD FOR OPENING AN AIRWAY BALLER, KELSEY E —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18261995 NON-INVASIVE CANCER DETECTION BASED ON DNA METHYLATION CHANGES KIM, YOUNG J 13d
18852335 METHODS AND COMPOSITIONS FOR POTENTIATION OF A LIGAND HAGHIGHATIAN, MINA —
18888122 BIOLOGICAL SAMPLE EXTRACTION BUFFER, AND APPLICATION AND METHOD THEREOF BLUMEL, BENJAMIN P —
18749431 PRESSURE CONTROL SYSTEM, DEVICE AND METHOD FOR OPENING AN AIRWAY BALLER, KELSEY E —
18711585 WHOLE GENOME CPG ANALYSIS KIM, YOUNG J —
18579268 FLAVOR COMPOSITION GWARTNEY, ELIZABETH A —

Client Portfolio (22 clients)

Top Art Units

Art UnitApps
16322
17982
16112
24351
16621
37961
16221
17591
28551
16251

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19025540 MULTI FACTOR AUTHENTICATION Coronet Cyber Security Ltd. SONG, HOSUK 2435 DP Final Rejection — Pending Jan 16, 2025
18852335 METHODS AND COMPOSITIONS FOR POTENTIATION OF A LIGAND National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government HAGHIGHATIAN, MINA §102§103§112Other Non-Final OA — Pending Sep 27, 2024
18888122 BIOLOGICAL SAMPLE EXTRACTION BUFFER, AND APPLICATION AND METHOD THEREOF Leadway (Hk) Limited BLUMEL, BENJAMIN P §102§103§112 Non-Final OA — Pending Sep 17, 2024
18749431 PRESSURE CONTROL SYSTEM, DEVICE AND METHOD FOR OPENING AN AIRWAY Ttp PLC BALLER, KELSEY E §103§112 Non-Final OA — Pending Jun 20, 2024
18737469 METHODS FOR NON-TRANSGENIC GENOME EDITING IN PLANTS Cellectis COLLINS, CYNTHIA E 1662 §103§112 Non-Final OA — Pending Jun 07, 2024
18711585 WHOLE GENOME CPG ANALYSIS Nucleix Ltd. KIM, YOUNG J §103§112 Non-Final OA — Pending May 18, 2024
18642557 BODY-WORN VITAL SIGN MONITOR Sotera Wireless, Inc. GEDEON, BRIAN T 3796 DPOther Non-Final OA — Pending Apr 22, 2024
18693887 AUTOTAXIN-INHIBITORS Universitaet Muenster DEKARSKE, MADELINE MCGUIRE 1622 §101§102§103§112 Non-Final OA — Pending Mar 20, 2024
18290710 METHOD OF PRODUCING A POPULATION OF IMMUNE CELLS FROM PLURIPOTENT STEM CELLS Repairon Immuno GmbH CESARE, JOSEPH DAVID §101§103§112 Non-Final OA — Pending Jan 19, 2024
18579268 FLAVOR COMPOSITION Planet A Foods GmbH GWARTNEY, ELIZABETH A 1759 §102§112 Non-Final OA — Pending Jan 12, 2024
18036054 DETECTION PLATE HAVING IDENTIFICATION INFORMATION AND ANALYZER FOR READING IDENTIFICATION INFORMATION AND IDENTIFICATION METHOD THEREFOR Leadway (Hk) Limited WILLIAMS, JAMEL E 2855 §103 Non-Final OA — Pending Nov 10, 2023
18559019 TOPICAL NAPROXEN FORMULATIONS AND THEIR USE Smartech Topical, Inc. BELL, SARA ELIZABETH 1625 §103§112DP Non-Final OA — Pending Nov 03, 2023
18264046 SOLE USE OF POLYMERSOME ASSOCIATED ADJUVANT FOR STIMULATING AN IMMUNE RESPONSE Acm Biolabs Pte. Ltd. YU, DAVID TUYANG 1635 §102§103§112 Non-Final OA — Pending Aug 02, 2023
18262441 APPLICATION OF PERMITTIVITY MEASUREMENT PROBES IN AN SUSPENSION CULTURE AGGREGATE COMPRISING CELL AGGREGATES Repairon GmbH JOHNSON, KARA D 1632 §103§112 Non-Final OA — Pending Jul 21, 2023
18262433 METHOD OF CHANGING CULTURE MEDIUM OF A CULTURE USING SPINFILTERS Repairon GmbH MARTIN, PAUL C 1653 §103 Final Rejection 19d Pending Jul 21, 2023
18261995 NON-INVASIVE CANCER DETECTION BASED ON DNA METHYLATION CHANGES Nucleix Ltd. KIM, YOUNG J 1681 §101§103§112 Final Rejection 13d Pending Jul 18, 2023
18036123 TEST DEVICE AND TEST PAPER Leadway (Hk) Limited JARRETT, LORE RAMILLANO 1797 §103§112 Final Rejection 97d overdue Pending May 09, 2023
18144244 COMPOSITION AND METHODS FOR SENSITIVE MOLECULAR ANALYSIS Trust Bio-Sonics, Inc. LI, JOHN DENNY 3798 §112 Non-Final OA — Pending May 08, 2023
18006136 A METHOD OF GENERATING AN INDUCED PLURIPOTENT STEM CELL, AN INDUCED PLURIPOTENT STEM CELL AND METHODS OF USING THE INDUCED PLURIPOTENT STEM CELL Singapore Health Services Pte. Ltd. MOLOYE, TITILAYO 1632 §103§112 Non-Final OA — Pending Jan 19, 2023
18092420 METHODS AND COMPOSITIONS FOR INCREASING EFFICIENCY OF TARGETED GENE MODIFICATION USING OLIGONUCLEOTIDE-MEDIATED GENE REPAIR Cibus Europe B.V. BOGGS, RUSSELL T 1663 §103Other Final Rejection 28d Pending Jan 02, 2023
18003869 INTERNAL FIXING DEVICE FOR APPARATUS IN TRANSPORT MODE, APPARATUS COMPRISING INTERNAL FIXING DEVICE, AND METHOD FOR REDUCING DAMAGE TO APPARATUS DURING TRANSPORT Leadway (Hk) Limited BRAZIN, JACQUELINE 1798 §103 Non-Final OA — Pending Dec 29, 2022
17999185 MEK-INHIBITORS FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTIONS AND/OR COVID-19 CYTOKINE STORM Atriva Therapeutics GmbH NESTOR, DONNA MICHELLE 1627 §103§112Other Non-Final OA 89d overdue Pending Nov 17, 2022
17836455 SANITIZING ARTICLES FOR LUER ACCESS DEVICES Cleansite Medical, Inc. KIPOUROS, HOLLY MICHAELA 1799 §102§103§112DP Non-Final OA — Pending Jun 09, 2022
17700356 METHOD AND DEVICE FOR PRODUCING OPTIMIZED LIPID-BASED MICRO/NANO-BUBBLES Trust Bio-Sonis Inc. HOWELL, MARC C 1618 §103§112 Non-Final OA — Pending Mar 21, 2022
17617190 SYSTEM AND METHOD FOR REAL-TIME MULTICOLOR SHORTWAVE INFRARED FLUORESCENCE IMAGING The Regents of the University of California FAYE, MAMADOU 2884 §103§112 Non-Final OA 74d overdue Pending Dec 07, 2021
17617284 MICROFLUIDIC CHIP AND MANUFACTURING METHOD THEREFOR Leadway (Hk) Limited KASS, BENJAMIN JOSEPH 1798 §102§103§112 Final Rejection 73d overdue Pending Dec 07, 2021
17276023 POLYMERSOMES COMPRISING A COVALENTLY BOUND ANTIGEN AS WELL AS METHODS OF MAKING AND USES THEREOF Acm Biolabs Pte. Ltd. HOERNER, PAUL ELLSWORTH 1611 §103 Final Rejection — Pending Mar 12, 2021
17259581 USE OF BCL6 INHIBITORS FOR TREATING AUTOIMMUNE DISEASES Teqla Therapeutics Inc. BAEK, BONG-SOOK 1611 §103 Non-Final OA — Pending Jan 12, 2021
16622825 METHODS FOR PURIFYING ENDODERM AND PANCREATIC ENDODERM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS Miltenyi Biotec B.V. & Co. KG GONZALES, JOSEPHINE MARIA 1631 §103 Non-Final OA — Pending Dec 13, 2019

Managing Acuity Law Group, P.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month